openPR Logo
Press release

Metabolomics Market is growing with double digit CAGR of 13.2% upto 2023 | Top 3 Key players are Agilent Technologies, Danaher Corporation, Biocrates Life Sciences AG

06-19-2019 08:45 PM CET | Health & Medicine

Press release from: Allied Market Research

Metabolomics Market

Metabolomics Market

The Global Metabolomics Market is expected to garner $3.30 billion by 2023, growing a CAGR of 13.2% from 2017 to 2023. North America contributed the highest market share in 2017; while, Asia-Pacific is expected to experience the highest growth rate during the forecast period.

Download the Sample Report @ http://bit.ly/2L0wt8E

The report offers insights on drivers, restraints, and opportunities of the global metabolomics market. Surge in adoption of metabolomics in precision medicine and rise in R&D investments are expected to facilitate the market growth. In addition, technological advancements for auxiliary medical devices utilized for analysis of metabolomics and rise in demand of quality medications supplements the growth of the market. However, expensive medical devices and lack of effective data management for profiling of metabolomics restrain the market growth.

The report provides an extensive analysis of the global metabolomics market based on product & service, application, indication, and geography. Based on product & service, the report segments the market into metabolomics instruments and metabolomics bioinformatics tools & services. The application segment is further classified into biomarker discovery, toxicology testing, drug discovery, functional genomics, nutrigenomics, personalized medicine, and others. Based on indication, the report bifurcates the market into cancer, neurological disorders, cardiovascular disorders, inborn errors of metabolism, and others. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The biomarker discovery segment contributed the highest market share in 2017, and will maintain its dominant share during the forecast period. Advancements in quantification methods & technologies along with rise in concerns regarding prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer would fuel the growth of this segment.

For More Inquiry @ http://bit.ly/2WWjw24

Key Findings of the report:
• The drug discovery segment is anticipated to witness the highest grow rate during the forecast period.
• The biomarker discovery segment generated the highest market share in 2017 and is expected to maintain its dominance in the during the forecast period.
• North America dominated the global metabolomics market in 2017.
• China would register the highest CAGR in the Asia-Pacific region.

North America held the major market share in 2017, owing to surge in R&D investments and availability of advanced healthcare facilities. In addition, rise in usage of experimental medicines and increase in adoption of metabolomics for precision medicine fuel the growth. However, Asia-pacific would grow at the highest CAGR during the forecast period owing to increase in adoption of metabolomics in medical research and increase in government initiatives for finding cost-effective treatments for chronic diseases.

The key companies analyzed in the report include Agilent Technologies, Inc., Biocrates Life Sciences AG, Danaher Corporation, Leco Corporation, Bruker Corporation, Human Metabolome Technologies, Inc., Metabolon, Inc., Shimadzu Corporation, Bio-Rad Laboratories, Inc., Waters Corporation, and Thermo Fisher Scientific Inc.

Contact Us:-
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:-
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Metabolomics Market is growing with double digit CAGR of 13.2% upto 2023 | Top 3 Key players are Agilent Technologies, Danaher Corporation, Biocrates Life Sciences AG here

News-ID: 1781637 • Views: 1626

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Metabolomics

Metabolomics Market Competition is Cutthroat over 2025
Global Metabolomics Market: Snapshot Metabolomics is the examination of small molecules, commonly known as metabolites. Such molecules are typically found inside cells, tissues, biofluids, or organisms. The interaction of such small molecules in a biological system are known as the metabolome. Metabolomics is done on a large scale. Metabolomics is a powerful tool since metabolites and their concentrations directly reveal the underlying biochemical activity and condition of cells and tissues. The four
Metabolomics Market - Global Regional Outlook 2017 - 2025
Global Metabolomics Market: Snapshot Metabolomics is the examination of small molecules, commonly known as metabolites. Such molecules are typically found inside cells, tissues, biofluids, or organisms. The interaction of such small molecules in a biological system are known as the metabolome. Metabolomics is done on a large scale. Metabolomics is a powerful tool since metabolites and their concentrations directly reveal the underlying biochemical activity and condition of cells and tissues. The four
Metabolomics Market Segmentation Analysis
A large pool of players with a robust presence points towards the high degree of competition in the global metabolomics.market Thermo Fisher, Biocrates Life Sciences, Agilent Technologies, Shimadzu, Human Metabolome Technologies, Waters, Metabolon, LECO, Bruker, and Bio-Rad Laboratories are some of the key companies leading this market, finds a new research report by Transparency Market Research (TMR). Hitherto, these companies have relied upon innovation and product advancements for the growth of
Global Metabolomics Market $1.4 Billion by 2021
The global metabolomics market is estimated to reach $1. 4 Billion in 2021, growing at a CAGR of 15.6% from 2017 to 2021, according to a market research report Metabolomics Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc. The metabolomics market report estimates the market size (Revenue $million - 2014 to 2021) and key market segments based on detection and separation techniques used, its applications (biomarker discovery, clinical toxicology, drug
Metabolomics Market: Future Demand and Growth Analysis
Metabolomics is the extensive study of small molecules, generally known as metabolites, within cells, biofluids, tissues or organisms. Together, these small molecules and their interactions in a biological system are known as the metabolome. Metabolomics involves the study of substrates and products of metabolism, which are affected by genetic and environmental factors. With the increasing applications of metabolomics in life sciences, the demand is increasing gradually. Metabolomics is gaining more
Metabolomics Market: Overview & Sector Analysis (2016 - 2024)
Biomarker discovery segment to be the largest share of the global metabolomics market The global metabolomics market is segmented on the basis of metabolomics instruments, application, indication, and geography. On the basis of metabolomics instrument, the metabolomics market is segmented into separation technique and detection technique. The separation technique is further segmented into gas chromatography, capillary electrophoresis, high-performance liquid chromatography, and ultra-performance liquid chromatography. The detection technique is further segmented into